Allena Pharmaceuticals logo
Allena Pharmaceuticals ALNA

Quarterly report 2022-Q2
added 08-15-2022

report update icon

Allena Pharmaceuticals Total Current Liabilities 2011-2026 | ALNA

Annual Total Current Liabilities Allena Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
15.7 M 6.12 M 10.9 M 5.76 M 7.54 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
15.7 M 5.76 M 9.2 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
AbbVie AbbVie
ABBV
43.3 B $ 208.84 -2.86 % $ 369 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
64.3 M $ 3.52 0.28 % $ 1.05 B canadaCanada
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
194 M $ 74.21 -2.3 % $ 1.43 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
73.4 M $ 1.41 2.17 % $ 375 M britainBritain
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
2.21 M $ 1.51 48.04 % $ 17 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
759 M $ 55.5 -3.04 % $ 10.6 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
6.18 M - 10.36 % $ 9.8 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
36.4 M $ 8.03 2.29 % $ 220 M israelIsrael
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
89.9 M $ 14.81 2.63 % $ 2.25 B usaUSA
Altimmune Altimmune
ALT
15 M $ 3.34 7.05 % $ 294 M usaUSA
Amgen Amgen
AMGN
25.5 B $ 347.94 -1.51 % $ 187 B usaUSA
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
93.7 M $ 15.61 0.9 % $ 2.1 B canadaCanada
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
23.4 B $ 59.6 -2.45 % $ 121 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
160 M $ 9.02 -3.84 % $ 1.86 B usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
1.1 M - -52.27 % $ 4.45 M usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
39.8 M $ 5.76 1.95 % $ 469 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
1.83 B - 0.49 % $ 251 B cayman-islandsCayman-islands
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Biogen Biogen
BIIB
3.35 B $ 177.34 -3.5 % $ 26 B usaUSA
Axcella Health Axcella Health
AXLA
14.1 M - -16.42 % $ 249 M usaUSA
Axon Enterprise Axon Enterprise
AXON
1.68 B $ 412.81 -2.54 % $ 31.3 B usaUSA